MX2018001556A - Membranas implantables de grafeno con baja citotoxicidad. - Google Patents

Membranas implantables de grafeno con baja citotoxicidad.

Info

Publication number
MX2018001556A
MX2018001556A MX2018001556A MX2018001556A MX2018001556A MX 2018001556 A MX2018001556 A MX 2018001556A MX 2018001556 A MX2018001556 A MX 2018001556A MX 2018001556 A MX2018001556 A MX 2018001556A MX 2018001556 A MX2018001556 A MX 2018001556A
Authority
MX
Mexico
Prior art keywords
enclosure
environment
substances
implantable
low cytotoxicity
Prior art date
Application number
MX2018001556A
Other languages
English (en)
Inventor
V Bedworth Peter
E Heise Scott
L Swett Jacob
M Simon Sarah
Original Assignee
Lockheed Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lockheed Corp filed Critical Lockheed Corp
Publication of MX2018001556A publication Critical patent/MX2018001556A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/02—Inorganic materials
    • A61L31/024—Carbon; Graphite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/082—Inorganic materials
    • A61L31/084—Carbon; Graphite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/12—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L31/121—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix
    • A61L31/122—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix of carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/146—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/64—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00—Materials or methods for coatings medical devices
    • A61L2420/04—Coatings containing a composite material such as inorganic/organic, i.e. material comprising different phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00—Materials or methods for coatings medical devices
    • A61L2420/08—Coatings comprising two or more layers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Materials Engineering (AREA)
  • Composite Materials (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Prostheses (AREA)

Abstract

Se pueden formar materiales bidimensionales en recintos para varias sustancias y se puede proveer una capa de sustrato en la parte exterior e interior del recinto, en donde el recinto no es citotóxico. Los recintos pueden ser expuestos a un entorno, tal como un biológico (in vivo o in vitro), en donde la capa fibrosa puede promover el crecimiento vascular interno. Una o más sustancias dentro del recinto pueden ser liberadas al medio, una o más sustancias seleccionadas pueden entrar del medio al recinto, una o más sustancias del medio pueden ser restringidas de entrar al recinto, una o más sustancias pueden ser retenidas dentro del recinto, o combinaciones de las mismas. El recinto puede por ejemplo, permitir un paradigma de respuesta sensorial se lleva a cabo. El recinto puede, por ejemplo, proveer inmunoaislamiento de materiales, como lo son las células vivas retenidas en el mismo.
MX2018001556A 2015-08-06 2016-04-14 Membranas implantables de grafeno con baja citotoxicidad. MX2018001556A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562202056P 2015-08-06 2015-08-06
US15/099,193 US20170035943A1 (en) 2015-08-06 2016-04-14 Implantable graphene membranes with low cytotoxicity
PCT/US2016/027616 WO2017023379A1 (en) 2015-08-06 2016-04-14 Implantable graphene membranes with low cytotoxicity

Publications (1)

Publication Number Publication Date
MX2018001556A true MX2018001556A (es) 2018-09-17

Family

ID=57943457

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018001556A MX2018001556A (es) 2015-08-06 2016-04-14 Membranas implantables de grafeno con baja citotoxicidad.

Country Status (8)

Country Link
US (1) US20170035943A1 (es)
JP (1) JP2018521806A (es)
KR (1) KR20180059429A (es)
AU (1) AU2016304005A1 (es)
CA (1) CA2994934A1 (es)
IL (1) IL257369A (es)
MX (1) MX2018001556A (es)
WO (1) WO2017023379A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10005038B2 (en) 2014-09-02 2018-06-26 Lockheed Martin Corporation Hemodialysis and hemofiltration membranes based upon a two-dimensional membrane material and methods employing same
US10980919B2 (en) 2016-04-14 2021-04-20 Lockheed Martin Corporation Methods for in vivo and in vitro use of graphene and other two-dimensional materials
US10653824B2 (en) * 2012-05-25 2020-05-19 Lockheed Martin Corporation Two-dimensional materials and uses thereof
US10376845B2 (en) 2016-04-14 2019-08-13 Lockheed Martin Corporation Membranes with tunable selectivity
TW201504140A (zh) 2013-03-12 2015-02-01 Lockheed Corp 形成具有均勻孔尺寸之多孔石墨烯之方法
US9572918B2 (en) 2013-06-21 2017-02-21 Lockheed Martin Corporation Graphene-based filter for isolating a substance from blood
EP3099645A4 (en) 2014-01-31 2017-09-27 Lockheed Martin Corporation Processes for forming composite structures with a two-dimensional material using a porous, non-sacrificial supporting layer
WO2017023376A1 (en) 2015-08-05 2017-02-09 Lockheed Martin Corporation Perforatable sheets of graphene-based material
AU2016303049A1 (en) 2015-08-06 2018-03-01 Lockheed Martin Corporation Nanoparticle modification and perforation of graphene
JP2019519756A (ja) 2016-04-14 2019-07-11 ロッキード・マーチン・コーポレーション 欠陥形成または欠陥修復をその場で監視して制御する方法
WO2017180137A1 (en) 2016-04-14 2017-10-19 Lockheed Martin Corporation Method for treating graphene sheets for large-scale transfer using free-float method
CA3020874A1 (en) 2016-04-14 2017-10-19 Lockheed Martin Corporation Two-dimensional membrane structures having flow passages
CA3020880A1 (en) 2016-04-14 2017-10-19 Lockheed Martin Corporation Selective interfacial mitigation of graphene defects
WO2019004379A1 (ja) 2017-06-29 2019-01-03 富士フイルム株式会社 移植用チャンバーおよび移植用デバイス
JP6941175B2 (ja) * 2017-08-30 2021-09-29 富士フイルム株式会社 細胞移植用デバイスおよびその製造方法
WO2019044991A1 (ja) 2017-08-30 2019-03-07 富士フイルム株式会社 血管新生剤およびその製造方法
US11680243B2 (en) 2019-02-20 2023-06-20 Iowa State University Research Foundation, Inc. Conductive graphene matrix-encapsulated cells

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995018583A1 (en) * 1994-01-11 1995-07-13 Baxter International Inc. Ported tissue implant systems and methods of using same
US8246917B2 (en) 2006-06-23 2012-08-21 Johns Hopkins University Self-assembled, micropatterned, and radio frequency (RF) shielded biocontainers and their uses for remote spatially controlled chemical delivery
LT2470228T (lt) * 2009-08-28 2018-02-12 Sernova Corporation Būdai ir įrenginiai ląstelinei transplantacijai
US8828211B2 (en) 2010-06-08 2014-09-09 President And Fellows Of Harvard College Nanopore device with graphene supported artificial lipid membrane
IN2014DN08466A (es) 2012-03-15 2015-05-08 Massachusetts Inst Technology
US20150050734A1 (en) 2012-03-27 2015-02-19 Duke University Carbon Nanotubes And Methods Of Use
US20130277305A1 (en) * 2012-04-19 2013-10-24 Lockheed Martin Corporation Selectively perforated graphene membranes for compound harvest, capture and retention
US20150258254A1 (en) 2014-03-12 2015-09-17 Lockheed Martin Corporation Methods for in vivo and in vitro use of graphene and other two-dimensional materials
US9403112B2 (en) * 2012-06-12 2016-08-02 The United States Of America As Represented By The Secretary Of The Air Force Graphene oxide filters and methods of use
CN104812470A (zh) 2012-11-30 2015-07-29 英派尔科技开发有限公司 支撑在纳米多孔石墨烯上的选择性膜
EP3099645A4 (en) 2014-01-31 2017-09-27 Lockheed Martin Corporation Processes for forming composite structures with a two-dimensional material using a porous, non-sacrificial supporting layer

Also Published As

Publication number Publication date
KR20180059429A (ko) 2018-06-04
US20170035943A1 (en) 2017-02-09
WO2017023379A1 (en) 2017-02-09
AU2016304005A1 (en) 2018-02-22
JP2018521806A (ja) 2018-08-09
CA2994934A1 (en) 2017-02-09
IL257369A (en) 2018-04-30

Similar Documents

Publication Publication Date Title
MX2018001556A (es) Membranas implantables de grafeno con baja citotoxicidad.
MX2016011812A (es) Uso in vivo e in vitro de grafeno.
GB2526228A (en) Combined organ and hematopoietic cells for transplantation tolerance of grafts
SG10201810723VA (en) Improved t cell compositions
SV2011003888A (es) Compuestos que expanden las celulas madre hematopoieticas
MX2012013752A (es) Producto medico con un recubrimiento libre de particulas que libera una sustancia activa.
CR20150604A (es) Proceso para la preparación de eritrocitos cargados con una o más sustancias de interés farmacéutico y eritrocitos así obtenidos
WO2017087759A8 (en) Cartridge-based system for long term culture of cell clusters
WO2014134084A3 (en) Phf20 and jmjd3 compositions and methods of use in cancer immunotherapy
WO2012037519A3 (en) Acceleration of wound healing by growth hormone releasing hormone and its agonists
MX2019005676A (es) Dispositivo percutáneo de difusión de gases adecuado para su uso con un implante subcutáneo.
AU2018337668A1 (en) Improved supraparticles
PH12018502061A1 (en) Differentiation of pluripotent stem cells to intestinal midgut endoderm cells
NZ731398A (en) Noscapinoid-producing microbes and methods of making and using the same
SG11202001906PA (en) Enrichment of nkx6.1 and c-peptide co-expressing cells derived in vitro from stem cells
MX2018006226A (es) Agente estimulador del receptor 1b de 5-hidroxitriptamina para mejorar el potencial de injerto in vivo.
WO2016160530A3 (en) Injection systems with storage compartments
IN2014DN10307A (es)
BR112017014017A2 (pt) sistemas e métodos para distribuição melhorada de moléculas osteoindutoras em reparo ósseo.
SG11201806445UA (en) Cell mass, cell structure, and three-dimensional tissue body
FR3062063B1 (fr) Microbiote fecal pour traiter des patients subissant une greffe de cellules souches hematopoietiques
WO2015054208A8 (en) Injectable compositions
CL2015001574A1 (es) Terapia combinada para el cancer
WO2015009829A3 (en) Enhancement of osteogenic potential of bone grafts
WO2016161311A8 (en) In-vitro methods for assessing tissue compatibility of a material